Get the Stockscreener App
689.93
1.65%
-11.55
After Hours:
689.93
Idexx Laboratories Inc stock is traded at $689.93, with a volume of 469.22K.
It is down -1.65% in the last 24 hours and up +8.32% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
See More
Previous Close:
$701.48
Open:
$695.92
24h Volume:
469.22K
Relative Volume:
1.03
Market Cap:
$55.20B
Revenue:
$4.17B
Net Income/Loss:
$1.03B
P/E Ratio:
54.69
EPS:
12.6148
Net Cash Flow:
$940.22M
1W Performance:
-2.61%
1M Performance:
+8.32%
6M Performance:
+35.43%
1Y Performance:
+62.85%
1-Day Range:
$688.66
$699.66
1-Week Range:
$688.66
$719.25
52-Week Range:
$356.14
$735.00
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
689.93 | 56.01B | 4.17B | 1.03B | 940.22M | 12.61 |
|
TMO
Thermo Fisher Scientific Inc
|
578.71 | 217.96B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
221.21 | 156.24B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
A
Agilent Technologies Inc
|
146.82 | 41.64B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
220.61 | 38.07B | 15.90B | 1.28B | 2.21B | 7.2842 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-25 | Upgrade | Stifel | Hold → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Aug-05-25 | Reiterated | BTIG Research | Buy |
| Jul-01-25 | Initiated | Jefferies | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
Why IDEXX Laboratories Inc. (IX1) stock stays undervalued2025 Macro Impact & Daily Entry Point Trade Alerts - newser.com
Why retail investors favor IDEXX Laboratories Inc. stockWeekly Earnings Recap & Real-Time Volume Trigger Notifications - newser.com
Quantitative breakdown of IDEXX Laboratories Inc. recent moveTrade Ideas & Community Trade Idea Sharing - newser.com
IDEXX Laboratories Amends Credit Agreement for Flexibility - TipRanks
Building trade automation scripts for IDEXX Laboratories Inc.2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com
Idexx Laboratories Shares Reach New Highs Amid Insider Selling Activity - AD HOC NEWS
Does IDEXX Laboratories Inc. fit your quant trading modelJuly 2025 Breakouts & Safe Entry Point Identification - newser.com
Insider Move: Nimrata Hunt Exercises Options, Realizing $4.10M At IDEXX Laboratories - Benzinga
Idexx Laboratories Insider Sold Shares Worth $6,629,014, According to a Recent SEC Filing - MarketScreener
IDEXX Laboratories Inc(IDXX.US) Officer Sells US$6.63 Million in Common Stock - 富途牛牛
Piper Sandler Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $775 - 富途牛牛
Here’s Why IDEXX Laboratories (IDXX) Surged in Q3 - Insider Monkey
Piper Sandler Adjusts Price Target on IDEXX Laboratories to $775 From $700 - MarketScreener
Is IDEXX Laboratories Inc. stock supported by strong cash flowsJuly 2025 Intraday Action & Expert Verified Movement Alerts - newser.com
Trend analysis for IDEXX Laboratories Inc. this weekFed Meeting & Capital Protection Trading Alerts - newser.com
Will IDEXX Laboratories Inc. stock recover after recent dropPortfolio Return Report & Weekly Breakout Stock Alerts - newser.com
What machine learning models say about IDEXX Laboratories Inc.2025 Trade Ideas & Real-Time Stock Price Movement Reports - newser.com
IDEXX Laboratories Hits Day High with 14.84% Surge in Stock Price - Markets Mojo
What analyst consensus implies for IDEXX Laboratories Inc. (IX1) stockQuarterly Risk Review & Weekly Top Gainers Alerts - newser.com
Why IDEXX Laboratories (IDXX) Is Up 13.6% After Strong Q3 Results and Raised 2025 Guidance - Yahoo Finance
Earnings Beat: IDEXX Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Will earnings trigger a reversal in IDEXX Laboratories Inc.2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Agree To Buy Idexx Laboratories At $600, Earn 5.3% Annualized Using Options - Nasdaq
Here’s Why Baron Focused Growth Fund Invested in IDEXX Laboratories (IDXX) - Insider Monkey
Is IDEXX Laboratories Inc. stock a safe buy before earningsJuly 2025 Earnings & Technical Buy Zone Confirmations - newser.com
Assessing IDEXX Laboratories After a 76% Rally and Surging Pet Healthcare Demand - Sahm
IDEXX Laboratories Reports Strong Q3 Earnings and Raises Guidance - The Globe and Mail
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
1.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):